When navigating a complex, evolving condition like multiple sclerosis, expert insights matter deeply. Here’s what top neurologists have to say about this condition.
When navigating a complex, evolving condition like multiple sclerosis, expert insights matter deeply. Here’s what top neurologists have to say about this condition.
The current landscape of MS care in India is fragmented. While we have made strides in treatment options, the lack of a centralized policy framework leaves thousands without timely access to life-changing therapies. MS must be integrated into the National Health Mission and recognized under the Rare Disease Policy and Ayushman Bharat to ensure equitable care and access to drugs. Additionally, insurance providers must update their coverage to include advanced Disease-Modifying Therapies (DMTs), which are proven to delay disability progression. Another critical gap is disability certification—many MS patients suffer from invisible symptoms like fatigue, cognitive fog, and neuropathic pain, which are not adequately recognized under current disability laws. We need revised guidelines that account for these challenges to ensure patients receive the financial and social support they deserve.
Neurologist
MS can be misdiagnosed with other neurological conditions like neuromyelitis optica, MOGAD, lupus, or even vitamin deficiencies. Early and accurate diagnosis is crucial because initiation of appropriate early treatment can prevent future disabilities. It is important to maintain NEDA (No evidence of disease activity). Relapses and PIRA cause lots of neurons leading to accumulating disability over time. Advanced imaging techniques (MRI) with special protocols for MS and demyelinating disorders and other blood/CSF biomarkers can improve diagnostic accuracy. Additionally, raising awareness among general physicians and the public about initial symptoms of MS—such as optic neuritis, unexplained numbness, or balance issues—can help reduce diagnostic delays, especially in smaller towns where neurologists are scarce.
Neurologist
The era of ‘one-size-fits-all’ MS treatment is ending. Today, we can tailor therapies based on a patient’s genetic predisposition, disease subtype (relapsing-remitting vs. progressive), and even lifestyle factors. For instance, patients with aggressive MS may benefit from early high-efficacy therapies (HETs), while others might respond better to oral DMTs. The future lies in precision medicine—combining clinical data, imaging, and molecular profiling to optimize outcomes while minimizing side effects.
Neurologist
Neurologist
MS patients don’t just battle physical symptoms—they fight misunderstanding, workplace discrimination, and social isolation. Many are told, ‘You look fine, how can you be sick?’ because their disability is invisible. This leads to depression, job loss, and even marital strain. We need awareness campaigns and workplace protections to empower patients.
Neurologist
Neurologist
In India, more than 1.5 lakh individuals, primarily young adults aged 20-40, are struggling with this condition in the absence of proper systemic support. The symptoms of MS are varied and differ in each person. These can involve fatigue, vision problems, weakness in the muscles, motor impairment, balance issues, cognitive problems, and even depression. These symptoms might get intensified over time, making performing everyday tasks a huge challenge for those afflicted by it. While the precise cause of MS is unknown, studies indicate that a combination of genetic predisposition and environmental exposures is implicated. MS cannot be cured, yet it can be treated. Disease-modifying therapies (DMTs) today are enhancing outcomes by lowering relapse rates as well as halting disease progression and preventing disability in the long run.
Neurologist
© 2025 F. Hoffmann-La Roche Ltd. All trademarks used or mentioned on this Website are protected by law.
The information on this Website is for awareness purposes only and should not be used to diagnose, treat, cure or prevent any disease without the advice of a qualified medical professional, and does not replace medical advice. Any and all opinions, statements, testimonials on this Website are those of the individual and not of Roche. This website is neither intended nor disguised for sale, marketing, promotion of any of Roche’s products. This website is neither intended nor designed to record or report adverse event information regarding any Roche product. If you have a suspected side effect or problem to report regarding one of our products, visit us at https://www.rocheindia.com/contact OR please call the Roche India Safety Unit on +91-98201 63752 or E-mail us at india.drugsafety@roche.com
